title: Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
authors.affiliation: III. Medizinische Klinik, Klinikum Mannheim, Universität Heidelberg, Germany.
authors.forename: R
authors.initials: R
authors.lastname: Hehlmann
authors.forename: H
authors.initials: H
authors.lastname: Ansari
authors.forename: J
authors.initials: J
authors.lastname: Hasford
authors.forename: H
authors.initials: H
authors.lastname: Heimpel
mesh_terms: D002066:Busulfan / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000473:pathology / Q000628:therapy*; D011379:Prognosis; D016019:Survival Analysis
chemical_list: D016898:Interferon-alpha; D002066:Busulfan; D006918:Hydroxyurea